| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 14, 2023 | WRBY Warby Parker Inc. | Miller Steven Clive64 | Chief Financial Officer | Sell | 10,875 | $12.22 | $132,892.50 | -6.1% | -5.7% | +93.7% | |
| Dec 14, 2023 | IRMD Iradimed Corp | Hawkins James B60 | Director | Sell | 10,468 | $43.60 | $456,406.89 | -5.1% | -1.2% | +15.6% | |
| Dec 13, 2023 | EW Edwards Lifesciences Corp | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sell | 8,000 | $71.86 | $574,880.00 | -16.8% | +20.9% | -1.7% | |
| Dec 13, 2023 | CTSO Cytosorbents Corp | Bloch Kathleen P. | Chief Financial Officer | Buy | 37,594 | $1.33 | $50,000.02 | +8.7% | -42.9% | -49.1% | |
| Dec 13, 2023 | CTSO Cytosorbents Corp | Sobel Alan D. | Director | Buy | 22,557 | $1.33 | $30,000.81 | +28.4% | -42.9% | -49.1% | |
| Dec 13, 2023 | CTSO Cytosorbents Corp | Deliargyris Efthymios | Chief Medical Officer | Buy | 22,557 | $1.33 | $30,000.81 | +6.9% | -42.9% | -49.1% | |
| Dec 13, 2023 | BJDX Bluejay Diagnostics, Inc. | Dey Indranil | President And CEO | Buy | 500 | $3.27 | $1,635.00 | +1.8% | -72.8% | -99.6% | |
| Dec 13, 2023 | TMDX Transmedics Group, Inc. | Provost Miriam | VP, Global Regulatory Affairs | Sell | 4,122 | $75.10 | $309,562.20 | -5.4% | +10.7% | -14.1% | |
| Dec 13, 2023 | EW Edwards Lifesciences Corp | Mussallem Michael A65 | Director | Sell | 29,350 | $74.62 | $2,190,043.08 | -26.0% | +20.9% | -1.7% | |
| Dec 13, 2023 | PRCT Procept Biorobotics Corp | Waters Kevin | EVP, CFO | Sell | 71,465 | $40.05 | $2,862,216.13 | -68.1% | +20.0% | +121.5% | |
| Dec 13, 2023 | BJDX Bluejay Diagnostics, Inc. | Dey Svetlana | Director | Buy | 500 | $3.07 | $1,535.00 | +50.0% | -72.8% | -99.6% | |
| Dec 13, 2023 | CERS Cerus Corp | Bjerkholt Eric71 | Director | Buy | 10,000 | $1.62 | $16,200.00 | +7.6% | +18.2% | -1.7% | |
| Dec 13, 2023 | KRMD Koru Medical Systems, Inc. | Manko Joseph M. Jr.64 | Director, 10% Owner | Sell | 145,833 | $2.40 | $349,999.20 | -6.2% | -12.5% | +83.3% | |
| Dec 13, 2023 | CTSO Cytosorbents Corp | Kim Jiny | Director | Buy | 7,519 | $1.33 | $10,000.27 | +10.7% | -42.9% | -49.1% | |
| Dec 13, 2023 | EW Edwards Lifesciences Corp | Wood Larry L67 | Global President Tavr &Surg | Sell | 8,658 | $71.86 | $622,163.88 | -3.9% | +20.9% | -1.7% | |
| Dec 13, 2023 | CTSO Cytosorbents Corp | Chan Phillip P.56 | Chief Executive Officer | Buy | 75,188 | $1.33 | $100,000.04 | +7.6% | -42.9% | -49.1% | |
| Dec 13, 2023 | KRMD Koru Medical Systems, Inc. | Manko Joseph M. Jr.64 | Director, 10% Owner | Buy | 145,833 | $2.40 | $349,999.20 | +2.0% | -12.5% | +83.3% | |
| Dec 13, 2023 | SONX Sonendo, Inc. | Pudipeddi Vamsi Mohan Raj | Director | Buy | 600,000 | $0.05 | $30,000.00 | +126.4% | - | - | |
| Dec 13, 2023 | CTSO Cytosorbents Corp | Capponi Vincent52 | President &COO | Buy | 18,797 | $1.33 | $25,000.01 | +3.3% | -42.9% | -49.1% | |
| Dec 13, 2023 | RCEL Avita Medical, Inc. | Cook Jeremy Curnock | Director | Sell | 2,518 | $12.27 | $30,895.86 | -10.9% | +29.6% | -2.4% | |
| Dec 13, 2023 | CTSO Cytosorbents Corp | Bator Michael G. | Director | Buy | 37,594 | $1.33 | $50,000.02 | +42.8% | -42.9% | -49.1% | |
| Dec 13, 2023 | CTSO Cytosorbents Corp | Jones Edward Raymond | Director | Buy | 7,519 | $1.33 | $10,000.27 | +9.2% | -42.9% | -49.1% | |
| Dec 13, 2023 | INCY Incyte Corp | Tray Thomas55 | Principal Accounting Officer | Sell | 1,277 | $61.55 | $78,594.39 | -2.6% | -7.6% | +10.3% | |
| Dec 13, 2023 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 5,137 | $1.13 | $5,815.01 | - | +5.2% | -45.2% | |
| Dec 12, 2023 | RCEL Avita Medical, Inc. | O'Toole David D47 | CFO | Buy | 950 | $12.45 | $11,827.50 | +5.7% | +34.0% | +7.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.